Qlucore AB (QCORE) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): 106.36K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.04
• Revenue Growth: -19.87%
• EPS Growth: 5.18%
• Country: SE
• Employees: 21
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): -0.78
• Shares Outstanding: 42,900,500
• 10 Day Avg. Volume: 135,027
• 30 Day Avg. Volume: 106,359
• PEG Ratio: -0.01
• Price to Book (P/B): 0.12
• Price to Sales (P/S): 0.71
• P/FCF Ratio: -0.32
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 39 Underperform
• Price Target: kr0.42 ▲(0.71% Upside)

Qlucore AB's overall stock score is primarily impacted by its poor financial performance and valuation metrics, both of which are at the lowest end of the scale. The technical analysis also suggests bearish momentum, further contributing to the low score. The absence of earnings call data and corporate events means these factors did not influence the score.

Positive Factors

Low Leverage

A low debt-to-equity ratio indicates a conservative capital structure, reducing financial risk and providing stability in uncertain markets.

Strong Equity Ratio

A strong equity ratio suggests financial stability, providing a buffer against potential losses and enabling strategic investments without heavy reliance on debt.

Product Offering

Qlucore's focus on innovative software for genomics and proteomics positions it well in the growing life sciences sector, supporting long-term demand.

Negative Factors

Negative Revenue Growth

Declining revenue growth indicates potential challenges in market demand or competitive positioning, impacting long-term profitability and expansion.

Negative Margins

Deeply negative margins reflect cost inefficiencies or pricing challenges, threatening sustainable profitability and requiring strategic cost management.

Cash Flow Challenges

Operational inefficiencies leading to negative cash flow can strain liquidity, limiting the company's ability to invest in growth and innovation.

Qlucore AB Business Overview & Revenue Model

Company Description

Qlucore AB (publ) provides bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. Its products include Qlucore Omics Explorer, a bioinformatics AI software for research in life science, biotech, food, and plant industries, as well as academia; Qlucore Diagnostics, a software platform for multi-omics companion and precision diagnostics; and Qlucore Insights, a software for clinical data analysis. Qlucore AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

How the Company Makes Money

Qlucore generates revenue primarily through the sales of its software licenses and subscriptions for Qlucore Omics Explorer. The company offers different pricing tiers based on the features and support included, catering to a range of customers from academic institutions to pharmaceutical companies. In addition to direct software sales, Qlucore may also earn revenue from training services, technical support, and consulting services that help clients maximize the use of their software. The company has established partnerships with universities and research institutes, which not only enhance its credibility but also help in expanding its customer base, thus contributing to its overall earnings.

Qlucore AB Financial Statement Overview

Summary

Qlucore AB is facing significant financial challenges, with declining revenues and increasing losses impacting profitability. Negative margins and shrinking assets indicate operational and financial inefficiencies. Cash flow constraints further exacerbate the situation, posing risks to sustainability. The company must address these issues to improve its financial health and stability.

Income Statement

The income statement shows a concerning trend with declining revenues and increasing losses. Gross profit margins are negative, indicating the company incurs more costs than it generates in revenue. The net profit margin has deteriorated significantly, moving from positive to deeply negative values over the years, highlighting profitability challenges. Revenue growth is negative, reflecting a shrinking top line, and EBIT and EBITDA margins are also negative, indicating operational inefficiencies.

Balance Sheet

The balance sheet reflects a moderate financial position with a relatively low debt-to-equity ratio, suggesting manageable leverage. However, equity has decreased over time, and total assets have declined. The return on equity is negative, indicating the company is not generating profits from shareholders' equity. The equity ratio has diminished, reflecting a potential decline in financial stability.

Cash Flow

The cash flow statement reveals significant challenges with negative operating cash flow and free cash flow, which have worsened over time. The free cash flow to net income ratio is concerning, highlighting cash flow constraints amid persistent net losses. Although capital expenditures have been reduced, this hasn't translated into improved cash flow, indicating operational difficulties.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	9.34M	10.21M	14.37M	12.67M	14.12M	12.94M
Gross Profit	-10.74M	-9.75M	7.40M	5.80M	5.43M	4.42M
EBITDA	-13.53M	-15.44M	-14.98M	-15.30M	-11.21M	-5.45M
Net Income	-19.63M	-20.54M	-15.68M	-15.94M	-11.66M	-6.04M
Balance Sheet
Total Assets	67.16M	69.95M	90.01M	109.36M	121.90M	46.24M
Cash, Cash Equivalents and Short-Term Investments	6.05M	5.26M	28.62M	69.73M	97.97M	27.56M
Total Debt	1.85M	2.00M	3.18M	4.46M	5.33M	4.63M
Total Liabilities	15.30M	11.49M	10.90M	14.63M	11.34M	9.68M
Stockholders Equity	51.85M	58.47M	79.11M	94.73M	110.56M	36.56M
Cash Flow
Free Cash Flow	-21.61M	-22.38M	-39.47M	-27.06M	-15.76M	-5.24M
Operating Cash Flow	-14.71M	-14.15M	-16.95M	-8.05M	-6.81M	-1.08M
Investing Cash Flow	-6.90M	-8.22M	-22.52M	-19.02M	-8.95M	-4.16M
Financing Cash Flow	-964.00K	-1.18M	-1.27M	-808.00K	86.25M	28.28M

Qlucore AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.42
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:QCORE, the sentiment is Negative. The current price of 0.42 is below the 20-day moving average (MA) of 0.48, below the 50-day MA of 0.49, and below the 200-day MA of 0.75, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 38.97 is Neutral, neither overbought nor oversold. The STOCH value of 48.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:QCORE.

Qlucore AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
QCORE	39 Underperform	―	-0.17	―	―	-19.87%	5.18%